- Home
- PTIX vs MEGL Comparison
PTIX vs MEGL Comparison
Compare PTIX & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PTIX
- MEGL
- Stock Information
- Founded
- PTIX 1994
- MEGL 2016
- Country
- PTIX United States
- MEGL Hong Kong
- Employees
- PTIX N/A
- MEGL N/A
- Industry
- PTIX Biotechnology: Pharmaceutical Preparations
- MEGL Finance: Consumer Services
- Sector
- PTIX Health Care
- MEGL Finance
- Exchange
- PTIX Nasdaq
- MEGL Nasdaq
- Market Cap
- PTIX 6.3M
- MEGL 6.8M
- IPO Year
- PTIX 2016
- MEGL 2022
- Fundamental
- Price
- PTIX $2.76
- MEGL $1.41
- Analyst Decision
- PTIX
- MEGL
- Analyst Count
- PTIX 0
- MEGL 0
- Target Price
- PTIX N/A
- MEGL N/A
- AVG Volume (30 Days)
- PTIX 73.5K
- MEGL 38.5K
- Earning Date
- PTIX 11-13-2025
- MEGL 12-11-2025
- Dividend Yield
- PTIX N/A
- MEGL N/A
- EPS Growth
- PTIX N/A
- MEGL N/A
- EPS
- PTIX N/A
- MEGL N/A
- Revenue
- PTIX N/A
- MEGL $1,296,394.00
- Revenue This Year
- PTIX N/A
- MEGL N/A
- Revenue Next Year
- PTIX N/A
- MEGL N/A
- P/E Ratio
- PTIX N/A
- MEGL N/A
- Revenue Growth
- PTIX N/A
- MEGL N/A
- 52 Week Low
- PTIX $2.25
- MEGL $1.02
- 52 Week High
- PTIX $15.26
- MEGL $5.52
- Technical
- Relative Strength Index (RSI)
- PTIX 35.75
- MEGL 42.48
- Support Level
- PTIX $2.85
- MEGL $1.41
- Resistance Level
- PTIX $3.19
- MEGL $1.47
- Average True Range (ATR)
- PTIX 0.23
- MEGL 0.07
- MACD
- PTIX -0.04
- MEGL -0.02
- Stochastic Oscillator
- PTIX 5.61
- MEGL 12.00
About PTIX Protagenic Therapeutics Inc.
Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.
About MEGL Magic Empire Global Limited
Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.